Arvee Laboratories (India) Limited (ARVEE) - Total Liabilities

Latest as of September 2025: Rs91.40 Million INR ≈ $988.48K USD

Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has total liabilities worth Rs91.40 Million INR (≈ $988.48K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Arvee Laboratories (India) Limited operating cash flow efficiency to assess how effectively this company generates cash.

Arvee Laboratories (India) Limited - Total Liabilities Trend (2013–2025)

This chart illustrates how Arvee Laboratories (India) Limited's total liabilities have evolved over time, based on quarterly financial data. Check Arvee Laboratories (India) Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.

Arvee Laboratories (India) Limited Competitors by Total Liabilities

The table below lists competitors of Arvee Laboratories (India) Limited ranked by their total liabilities.

Company Country Total Liabilities
Energoaparatura S.A.
WAR:ENP
Poland zł15.31 Million
Hifab Group AB Series B
ST:HIFA-B
Sweden Skr60.58 Million
Euroconsultants SA
AT:EUROC
Greece €6.35 Million
Khadim India Limited
NSE:KHADIM
India Rs4.10 Billion
Clean Seas Seafood Ltd
AU:CSS
Australia AU$20.12 Million
OCB Bhd
KLSE:5533
Malaysia RM98.56 Million
Devonian Health Group Inc
V:GSD
Canada CA$5.97 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Arvee Laboratories (India) Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ARVEE stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.52 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.23 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arvee Laboratories (India) Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arvee Laboratories (India) Limited (2013–2025)

The table below shows the annual total liabilities of Arvee Laboratories (India) Limited from 2013 to 2025.

Year Total Liabilities Change
2025-03-31 Rs68.97 Million
≈ $745.87K
-24.08%
2024-03-31 Rs90.85 Million
≈ $982.46K
-14.48%
2023-03-31 Rs106.23 Million
≈ $1.15 Million
-27.94%
2022-03-31 Rs147.43 Million
≈ $1.59 Million
-24.81%
2021-03-31 Rs196.08 Million
≈ $2.12 Million
+31.28%
2020-03-31 Rs149.36 Million
≈ $1.62 Million
-27.80%
2019-03-31 Rs206.88 Million
≈ $2.24 Million
-30.85%
2018-03-31 Rs299.18 Million
≈ $3.24 Million
-4.96%
2017-03-31 Rs314.81 Million
≈ $3.40 Million
-3.34%
2016-03-31 Rs325.69 Million
≈ $3.52 Million
+32.32%
2015-03-31 Rs246.14 Million
≈ $2.66 Million
+71.40%
2014-03-31 Rs143.60 Million
≈ $1.55 Million
+62.92%
2013-03-31 Rs88.14 Million
≈ $953.24K
--

About Arvee Laboratories (India) Limited

NSE:ARVEE India Specialty Chemicals
Market Cap
$20.02 Million
Rs1.85 Billion INR
Market Cap Rank
#25030 Global
#1394 in India
Share Price
Rs168.00
Change (1 day)
-0.52%
52-Week Range
Rs133.86 - Rs290.78
All Time High
Rs306.70
About

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more